ELOX Relative Valuation - Eloxx Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.0808 USD -57.47% Market Closed

Market Cap: $253.7k

	Eloxx Pharmaceuticals Inc OTC:ELOX	US

Multiples-Based Value

There is not enough data to reliably calculate the multiples-based value of ELOX.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

ELOX Multiples-Based Value

Base Case

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Eloxx Pharmaceuticals Inc OTC:ELOX	8.8m USD	0	-0.5	-0.4	-0.4
US		Eli Lilly and Co NYSE:LLY	869B USD	13.3	42.1	28.4	30.3
US		Johnson & Johnson NYSE:JNJ	588.6B USD	6.2	22	15.2	18.7
CH		Roche Holding AG SIX:ROG	248.4B CHF	4.1	19.4	11.5	13
UK		AstraZeneca PLC LSE:AZN	227.8B GBP	5.3	30.5	16.9	23.7
US		Merck & Co Inc NYSE:MRK	297.7B USD	4.6	16.3	10.1	12.3
CH		Novartis AG SIX:NOVN	231.9B CHF	5.4	21.7	13.4	17.3
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
US		Pfizer Inc NYSE:PFE	159.7B USD	2.6	20.5	7.8	10.4
DK		Novo Nordisk A/S CSE:NOVO B	1T DKK	3.4	10.2	7.6	8.9
US		Bristol-Myers Squibb Co NYSE:BMY	122.1B USD	2.5	17.3	7.3	9

				Revenue Growth	P/S to Growth
US		Eloxx Pharmaceuticals Inc OTC:ELOX	Average P/S: 15 Not Available	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	13.3	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.2	6%	1
CH		Roche Holding AG SIX:ROG	4.1	4%	1
UK		AstraZeneca PLC LSE:AZN	5.3	7%	0.8
US		Merck & Co Inc NYSE:MRK	4.6	5%	0.9
CH		Novartis AG SIX:NOVN	5.4	5%	1.1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	2.6	-4%	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	2%	1.7
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
US		Eloxx Pharmaceuticals Inc OTC:ELOX	Average P/E: 22.2 Negative Multiple: -0.5	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	42.1	32%	1.3
US		Johnson & Johnson NYSE:JNJ	22	7%	3.1
CH		Roche Holding AG SIX:ROG	19.4	14%	1.4
UK		AstraZeneca PLC LSE:AZN	30.5	26%	1.2
US		Merck & Co Inc NYSE:MRK	16.3	14%	1.2
CH		Novartis AG SIX:NOVN	21.7	14%	1.6
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
US		Pfizer Inc NYSE:PFE	20.5	22%	0.9
DK		Novo Nordisk A/S CSE:NOVO B	10.2	1%	10.2
US		Bristol-Myers Squibb Co NYSE:BMY	17.3	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
US		Eloxx Pharmaceuticals Inc OTC:ELOX	Average EV/EBITDA: 49.4 Negative Multiple: -0.4	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	28.4	22%	1.3
US		Johnson & Johnson NYSE:JNJ	15.2	2%	7.6
CH		Roche Holding AG SIX:ROG	11.5	6%	1.9
UK		AstraZeneca PLC LSE:AZN	16.9	13%	1.3
US		Merck & Co Inc NYSE:MRK	10.1	3%	3.4
CH		Novartis AG SIX:NOVN	13.4	5%	2.7
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	7.8	-9%	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.6	1%	7.6
US		Bristol-Myers Squibb Co NYSE:BMY	7.3	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
US		Eloxx Pharmaceuticals Inc OTC:ELOX	Average EV/EBIT: 108.5 Negative Multiple: -0.4	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	30.3	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.7	6%	3.1
CH		Roche Holding AG SIX:ROG	13	6%	2.2
UK		AstraZeneca PLC LSE:AZN	23.7	21%	1.1
US		Merck & Co Inc NYSE:MRK	12.3	6%	2
CH		Novartis AG SIX:NOVN	17.3	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	10.4	-4%	N/A
DK		Novo Nordisk A/S CSE:NOVO B	8.9	2%	4.4
US		Bristol-Myers Squibb Co NYSE:BMY	9	-7%	N/A

Eloxx Pharmaceuticals Inc
OTC:ELOX

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

ELOX Competitors Multiples
Eloxx Pharmaceuticals Inc Competitors

See Also

Company

Help

Tools

Stocks

Eloxx Pharmaceuticals Inc OTC:ELOX

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

ELOX Competitors Multiples Eloxx Pharmaceuticals Inc Competitors

See Also

Company

Help

Tools

Stocks

Eloxx Pharmaceuticals Inc
OTC:ELOX

ELOX Competitors Multiples
Eloxx Pharmaceuticals Inc Competitors